<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04677751</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-MS-20-0743</org_study_id>
    <nct_id>NCT04677751</nct_id>
  </id_info>
  <brief_title>Clinical and Electrographic Changes in Responsive Neurostimulation System (RNS) Patients With Acupuncture Treatment</brief_title>
  <official_title>Clinical and Electrographic Changes in RNS System Patients With Acupuncture Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine effects of Acupuncture on a Patient's mood and&#xD;
      cognition,evaluate changes in clinically-reported seizure frequency and severity and analyze&#xD;
      effects of Acupuncture on electrographic epileptiform activity stored by the RNS System&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2021</start_date>
  <completion_date type="Anticipated">December 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent change in number of disabling clinical seizures</measure>
    <time_frame>Baseline,12 weeks post treatment</time_frame>
    <description>This will be measured by self reporting journals</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in seizure severity</measure>
    <time_frame>Baseline,12 weeks post treatment</time_frame>
    <description>This will be measured by self reporting journals</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in cognition and mood as assessed by the Quality Of Life In Epilepsy (QOLIE-10) questionnaire</measure>
    <time_frame>Baseline,12 weeks post treatment</time_frame>
    <description>This is a 10 item questionnaire. Score ranges from 1-6,a higher number indicating a worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in cognition and mood as assessed by the Patient Health Questionnaire (PHQ-9)</measure>
    <time_frame>Baseline,12 weeks post treatment</time_frame>
    <description>PHQ-9 score can range from 0 to 27,each of the 9 items can be scored from 0 (not at all) to 3 (nearly every day).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in cognition and mood as assessed by the Generalized Anxiety Disorder 7-item (GAD-7) scale</measure>
    <time_frame>Baseline,12 weeks post treatment</time_frame>
    <description>This is a 7 item questionnaire. Each question is scored form 0(not at alll) to 3(nearly every day)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average number of detections of seizures per-day (as stored by the RNS System)</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average number of detections of seizures per-day (as stored by the RNS System)</measure>
    <time_frame>end of 1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average number of detections of seizures per-day (as stored by the RNS System)</measure>
    <time_frame>end of 2 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average number of detections of seizures per-day (as stored by the RNS System)</measure>
    <time_frame>end of 3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average number of detections of seizures per-day (as stored by the RNS System)</measure>
    <time_frame>1 month after last treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Epilepsy</condition>
  <arm_group>
    <arm_group_label>Experimental group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Acupuncture intervention</intervention_name>
    <description>Participants will undergo 12 weeks of acupuncture therapy. There will be one 40 minute-1 hour. session per week.</description>
    <arm_group_label>Experimental group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient implanted with the RNS system&#xD;
&#xD;
          -  Patient can undergo 12 weeks of acupuncture&#xD;
&#xD;
          -  Patient is able remain on stable medications for 12 weeks&#xD;
&#xD;
          -  Patient is able to remain on stable Detection and Stimulation settings for 12 weeks&#xD;
&#xD;
          -  Patient or/and caregiver is able to understand and sign informed consent and HIPAA&#xD;
             authorization&#xD;
&#xD;
          -  Patient or caregiver able to maintain a seizure diary for duration of study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient and /or caregiver is unable to sign informed consent to study&#xD;
&#xD;
          -  Patient has a bleeding disorder, pacemaker, or pregnant&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Olga Rodziyevska, MS,PA-C</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas Health Science Center, Houston</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Olga Rodziyevska, MS,PA-C</last_name>
    <phone>(713) 500-5482</phone>
    <email>Olga.Rodziyevska@uth.tmc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ardonia N Tousant</last_name>
    <phone>(713) 500-5482</phone>
    <email>Ardonia.N.Tousant@uth.tmc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The University of Texas Health Science Center at Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olga Rodziyevska, MS,PA-C</last_name>
      <phone>713-500-5482</phone>
      <email>Olga.Rodziyevska@uth.tmc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Ardonia N Tousant</last_name>
      <phone>(713) 500-5482</phone>
      <email>Ardonia.N.Tousant@uth.tmc.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>December 15, 2020</study_first_submitted>
  <study_first_submitted_qc>December 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 21, 2020</study_first_posted>
  <last_update_submitted>October 13, 2021</last_update_submitted>
  <last_update_submitted_qc>October 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center, Houston</investigator_affiliation>
    <investigator_full_name>Olga Rodziyevska</investigator_full_name>
    <investigator_title>Physician Assistant</investigator_title>
  </responsible_party>
  <keyword>acupuncture</keyword>
  <keyword>RNS</keyword>
  <keyword>seizure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epilepsy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

